Parathyroid Carcinoma: An Up-to-Date Retrospective Multicentric Analysis.
Journal
International journal of endocrinology
ISSN: 1687-8337
Titre abrégé: Int J Endocrinol
Pays: Egypt
ID NLM: 101516376
Informations de publication
Date de publication:
2020
2020
Historique:
received:
13
11
2019
revised:
28
01
2020
accepted:
11
02
2020
entrez:
28
3
2020
pubmed:
28
3
2020
medline:
28
3
2020
Statut:
epublish
Résumé
Parathyroid carcinoma (PC) is a rare disease responsible for about 1% of primary hyperparathyroidism (PHPT) cases. PC usually has an indolent course, tough to differentiate from the benign causes of PHPT, and the only certain diagnosis is histologic. The gold standard surgical treatment is the en bloc resection associated with the homolateral thyroid loboistmectomy. The aim of this study was to underline the main differences between PC and benign PHPT, along with gathering epidemiological knowledge relative to PC in our region. Data from the regional cancer network (Rete Oncologica del Piemonte e della Valle d'Aosta) since 2007 have been reported, including 21 patients from three hospitals (AO S. Croce e Carle of Cuneo, AOU Città della Salute of Turin, and ASL Città di Torino). The incidence of the disease, gender, age at time of diagnosis, presence of renal and bone symptoms, serum calcium and PTH levels, surgical technique performed, and percentage of recurrence were analysed. PC data were than compared with a series of patients affected by benign PHPT, referred to ASL Città di Torino, Maria Vittoria Hospital, from 2007 to 2019. A PC incidence of 0.05 cases per 100,000 inhabitants was found in our region. Benign forms occurred more frequently in females (
Identifiants
pubmed: 32215010
doi: 10.1155/2020/7048185
pmc: PMC7079239
doi:
Types de publication
Journal Article
Langues
eng
Pagination
7048185Informations de copyright
Copyright © 2020 Francesco Quaglino et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Curr Treat Options Oncol. 2012 Mar;13(1):11-23
pubmed: 22327883
Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):877-889
pubmed: 30551989
Am J Surg. 1991 Oct;162(4):299-302
pubmed: 1683177
Curr Opin Otolaryngol Head Neck Surg. 2016 Apr;24(2):155-62
pubmed: 26771263
Hum Mutat. 2017 Dec;38(12):1621-1648
pubmed: 28881068
Clin Endocrinol (Oxf). 2016 Jul;85(1):29-36
pubmed: 26939543
Acta Otolaryngol. 2002 Jun;122(4):448-52
pubmed: 12126006
Ann Ital Chir. 2018;89:295-304
pubmed: 30337508
Ann Surg Oncol. 2005 Jul;12(7):526-32
pubmed: 15889214
Lancet Oncol. 2017 Aug;18(8):1022-1039
pubmed: 28687376
Osteoporos Int. 2017 Jan;28(1):1-19
pubmed: 27613721
Medicine (Baltimore). 1992 Jul;71(4):197-205
pubmed: 1518393
Int J Surg Case Rep. 2018;42:214-217
pubmed: 29353223
Ann Endocrinol (Paris). 2015 May;76(2):169-77
pubmed: 25910997
Pan Afr Med J. 2017 Jun 05;27:85
pubmed: 28819506
Oncol Lett. 2015 Dec;10(6):3363-3368
pubmed: 26788136
World J Surg. 2010 Nov;34(11):2611-20
pubmed: 20640422
Cancer. 2004 Mar 1;100(5):900-5
pubmed: 14983483
Ann Surg Oncol. 2015 Nov;22(12):3990-5
pubmed: 26077914
Endocr Pathol. 2008 Winter;19(4):221-5
pubmed: 19058032
World J Surg. 2010 Nov;34(11):2604-10
pubmed: 20480190
World J Surg. 2009 Nov;33(11):2343-54
pubmed: 19350316
J Clin Endocrinol Metab. 2014 Oct;99(10):3561-9
pubmed: 25162665
Semin Surg Oncol. 1997 Mar-Apr;13(2):134-41
pubmed: 9088069
J Bone Miner Res. 2008 Dec;23(12):1869-80
pubmed: 19016595
Turk Patoloji Derg. 2015;31 Suppl 1:80-97
pubmed: 26177319
Arch Pathol Lab Med. 2008 Aug;132(8):1251-62
pubmed: 18684024